Substantial evidence has established that the dysregulation of the PI3K/AKT signaling axis, particularly the significant attenuation of its phosphorylation level, disrupts glucose transporter 4 translocation, thereby perturbing glucose metabolism and potentially initiating insulin resistance [14]. The gene discussed is AKT1; the disease is Insulin resistance.